Attovia Therapeutics, Inc.
ATTO· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Income | -$18.66M | -$15.15M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Attovia Therapeutics, Inc. · CIK 2058707 · Engraved from SEC EDGAR